Hepatitis E: Diagnostic and Therapeutic Challenges
Journal: Archives of Hepatitis Research (Vol.3, No. 1)Publication Date: 2017-09-26
Authors : Mohammad K Parvez;
Page : 010-012
Keywords : ;
Abstract
Hepatitis E virus (HEV) is a globally important water and foodborne pathogen of acute and chronic hepatitis E [1,2]. HEV infection may be symptomatic or asymptomatic that has affected about one-third of world population with a case fatality rate of 1-2%, including 20-30% of infected pregnant women [3-5]. Though inherently hepatotropic causing fulminant liver failure and cirrhosis, HEV has recently evolved with extra hepatic manifestations where biochemical/serological evidence of infection is often modest or absent [6-8].
Other Latest Articles
- Relative and combined Effects of Ethanol and Hepatitis C Virus Infection on Serum Interleukin-17 Levels
- Hepatitis E: New Clinical and Public Health Problem on the Western World? Review
- Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis
- Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
- Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Last modified: 2019-01-17 20:30:21